As obesity clinical trials evolve, there is a growing emphasis on how decentralisation and new technologies can play a role.

"Americans are fat and getting fatter," wrote Reason's Ron Bailey in a March 2023 piece about obesity and the hope such ...

Newly released data shows that the U.S. may have reached peak obesity in 2020 — and the timing unsurprisingly coincides with ...

Medicare is prohibited by law from covering GLP-1 drugs for weight loss. But many beneficiaries can access the drugs anyway.

Researchers raise concerns in a recent commentary. Since 1990, the prevalence of childhood overweight and obesity has nearly ...

Danish biotech Zealand Pharma is targeting the "next generation" of weight loss drugs as competitors pile into a market ...

The United States has passed peak obesity, according to new data, suggesting that the sweeping uptake of weight-loss drugs ...

Rivus Pharmaceuticals Inc., a drug developer focused on obesity treatments, is considering a US initial public offering as ...

Sep. 23, 2024 — With Medicare now covering semaglutide for people with obesity and cardiovascular disease who don't have diabetes, a study looks at who that might ... A Simple Blood Test Warns ...

Eli Lilly’s CEO David Ricks is confident his company and peer Novo Nordisk are years ahead in the weight loss space, as ...

Researchers have developed a revolutionary magnetogenetics technology that can control brain circuits non-invasively using ...

A trade group representing compounding pharmacies sued the FDA for a “reckless and arbitrary” decision to remove Eli Lilly's ...